Setanaxib (GKT137831) is an Orally Active And Specific NOX1/4 Inhibitor for Cardiovascular Disease Research
NOX1 and NOX4 are two members of the NADPH oxidase family, as well as multiple transmembrane proteins on the cell membrane. NOX1/4 catalyzes oxygen and NADPH into superoxide radicals to participate…